Plasmin plays an essential role in amplification of psoriasiform skin inflammation in mice

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Li, Qun ^a   Ke, Fang ^a   Zhang, Weiwei ^a   Shen, Xiaoyan ^a   Xu, Qiannan ^a   Wang, Hong ^a   Yu, Xue Zhong ^b   Leng, Qibin ^c   Wang, Honglin ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c INSTITUTE PASTEUR OF SHANGHAI   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR6; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 23; LIPOCORTIN 2; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; PLASMIN; PLASMINOGEN; RECOMBINANT PROTEIN; CCR6 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PSORIASIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CASE CONTROL STUDY; CELL CULTURE; DISEASE COURSE; EAR; FEMALE; GENETICS; IMMUNOLOGY; INFLAMMATION; MALE; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; SKIN DISEASE;

MUS;

ANIMALS; CASE-CONTROL STUDIES; CELLS, CULTURED; CHEMOKINE CCL20; DISEASE PROGRESSION; EAR; FEMALE; FIBRINOLYSIN; HUMANS; INFLAMMATION; INTERLEUKIN-23; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; PLASMINOGEN; PSORIASIS; RECEPTORS, CCR6; SKIN DISEASES; T-LYMPHOCYTES;

EID: 79551642928     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016483     Document Type: Article

References (33)

1. Schon MP, Boehncke WH (2005) Psoriasis. N Engl J Med 352: 1899-1912.
2. Lund LR, Green KA, Stoop AA, Ploug M, Almholt K, et al. (2006) Plasminogen activation independent of uPA and tPA maintains wound healing in genedeficient mice. EMBO J 25: 2686-2697.
3. Sun H, Ringdahl U, Homeister JW, Fay WP, Engleberg NC, et al. (2004) Plasminogen is a critical host pathogenicity factor for group A streptococcal infection. Science 305: 1283-1286.
4. Gissler HM, Frank R, Kramer MD (1993) Immunohistochemical characterization of the plasminogen activator system in psoriatic epidermis. Br J Dermatol 128: 612-618.
5. Spiers EM, Lazarus GS, Lyons-Giordano B (1994) Expression of plasminogen activator enzymes in psoriatic epidermis. J Invest Dermatol 102: 333-338.
6. Jensen PJ, Baird J, Belin D, Vassalli JD, Busso N, et al. (1990) Tissue plasminogen activator in psoriasis. J Invest Dermatol 95: 13S-14S.
7. Fraki JE, Briggaman RA, Lazarus GS (1982) Uninvolved skin from psoriatic patients develops signs of involved psoriatic skin after being grafted onto nude mice. Science 215: 685-687.
8. Li Q, Laumonnier Y, Syrovets T, Simmet T (2007) Plasmin Triggers Cytokine Induction in Human Monocyte-Derived Macrophages. Arterioscler Thromb Vasc Biol 27: 1383-1389.
9. Bata-Csorgo Z, Hammerberg C, Voorhees JJ, Cooper KD (1995) Intralesional T-lymphocyte activation as a mediator of psoriatic epidermal hyperplasia. J Invest Dermatol 105: 89S-94S.
10. Clark RA, Kupper TS (2006) Misbehaving macrophages in the pathogenesis of psoriasis. J Clin Invest 116: 2084-2087.
11. Wang H, Peters T, Kess D, Sindrilaru A, Oreshkova T, et al. (2006) Activated macrophages are essential in a murine model for T cell-mediated chronic psoriasiform skin inflammation. J Clin Invest 116: 2105-2114.
12. Zheng Y, Danilenko DM, Valdez P, Kasman I, Eastham-Anderson J, et al. (2007) Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445: 648-651.
13. Homey B, Dieu-Nosjean M-C, Wiesenborn A, Massacrier C, Pin J-J, et al. (2000) Up-Regulation of Macrophage Inflammatory Protein-3{alpha}/CCL20 and CC Chemokine Receptor 6 in Psoriasis. J Immunol 164: 6621-6632.
14. Kagami S, Rizzo HL, Lee JJ, Koguchi Y, Blauvelt A. Circulating Th17, Th22, and Th1 cells are increased in psoriasis. J Invest Dermatol 130: 1373-1383.
15. Hedrick MN, Lonsdorf AS, Shirakawa AK, Richard Lee CC, Liao F, et al. (2009) CCR6 is required for IL-23-induced psoriasis-like inflammation in mice. J Clin Invest 119: 2317-2329.
16. Harper EG, Guo C, Rizzo H, Lillis JV, Kurtz SE, et al. (2009) Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis. J Invest Dermatol 129: 2175-2183.
17. Carmody RJ, Ruan Q, Liou HC, Chen YH(2007) Essential roles of c-Rel in TLRinduced IL-23 p19 gene expression in dendritic cells. J Immunol 178: 186-191.
18. Lee E, Trepicchio WL, Oestreicher JL, Pittman D, Wang F, et al. (2004) Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. J Exp Med 199: 125-130.
19. Chan JR, Blumenschein W, Murphy E, Diveu C, Wiekowski M, et al. (2006) IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis. J Exp Med 203: 2577-2587.
20. Nair RP, Duffin KC, Helms C, Ding J, Stuart PE, et al. (2009) Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet 41: 199-204.
21. Wang H, Syrovets T, Kess D, Buchele B, Hainzl H, et al. (2009) Targeting NFkappaB with a natural triterpenoid alleviates skin inflammation in a mouse model of psoriasis. J Immunol 183: 4755-4763.
22. Gong Y, Kim S-OK, Felez J, Grella DK, Castellino FJ, et al. (2001) Conversion of Glu-Plasminogen to Lys-Plasminogen Is Necessary for Optimal Stimulation of Plasminogen Activation on the Endothelial Cell Surface. Journal of Biological Chemistry 276: 19078-19083.
23. Jensen PJ, Baird J, Morioka S, Lessin S, Lazarus GS (1988) Epidermal plasminogen activator is abnormal in cutaneous lesions. J Invest Dermatol 90: 777-782.
24. Menell JS, Cesarman GM, Jacovina AT, McLaughlin MA, Lev EA, et al. (1999) Annexin II and bleeding in acute promyelocytic leukemia. N Engl J Med 340: 994-1004.
25. Herren T, Burke TA, Jardi M, Felez J, Plow EF (2001) Regulation of plasminogen binding to neutrophils. Blood 97: 1070-1078.
26. Longstaff C, Merton RE, Fabregas P, Felez J (1999) Characterization of cellassociated plasminogen activation catalyzed by urokinase-type plasminogen activator, but independent of urokinase receptor (uPAR, CD87). Blood 93: 3839-3846.
27. Lijnen HR, De Cock F, Van Hoef B, Schlott B, Collen D (1994) Characterization of the interaction between plasminogen and staphylokinase. Eur J Biochem 224: 143-149.
28. Karimi-Busheri F, Marcoux Y, Tredget EE, Li L, Zheng J, et al. (2002) Expression of a releasable form of annexin II by human keratinocytes. J Cell Biochem 86: 737-747.
29. Hajjar KA, Menell JS (1997) Annexin II: a novel mediator of cell surface plasmin generation. Ann N Y Acad Sci 811: 337-349.
30. Semov A, Moreno MJ, Onichtchenko A, Abulrob A, Ball M, et al. (2005) Metastasis-associated Protein S100A4 Induces Angiogenesis through Interaction with Annexin II and Accelerated Plasmin Formation. Journal of Biological Chemistry 280: 20833-20841.
31. Zibert JR, Skov L, Thyssen JP, Jacobsen GK, Grigorian M (2009) Significance of the S100A4 Protein in Psoriasis. J Invest Dermatol 130: 150-160.
32. Pene J, Chevalier S, Preisser L, Venereau E, Guilleux MH, et al. (2008) Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. J Immunol 180: 7423-7430.
33. Sugiyama H, Gyulai R, Toichi E, Garaczi E, Shimada S, et al. (2005) Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation. J Immunol 174: 164-173.